Avidity Biosciences
RNA
#3153
Rank
A$5.91 B
Marketcap
$49.18
Share price
-3.17%
Change (1 day)
31.28%
Change (1 year)

Avidity Biosciences (RNA) - Cash on Hand

Cash on Hand as of December 2024 : A$2.37 Billion

According to Avidity Biosciences's latest financial reports the company has A$2.37 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Avidity Biosciences - Cash on Hand chart (from 2019 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31A$2.41 B176.25%
2023-12-31A$0.87 B-2.63%
2022-12-31A$0.89 B60.44%
2021-12-31A$0.55 B31.08%
2020-12-31A$0.42 B215.91%
2019-12-31A$0.13 B2979.72%
2018-12-31A$4.38 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$1.80 B-24.10%๐Ÿ‡บ๐Ÿ‡ธ USA
A$14.8 M-99.38%๐Ÿ‡บ๐Ÿ‡ธ USA
A$2.14 B-9.77%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.81 B-65.53%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.44 B-81.41%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
A$32.37 B 1,263.77%๐Ÿ‡บ๐Ÿ‡ธ USA
A$7.36 B 210.40%๐Ÿ‡ฌ๐Ÿ‡ง UK